List of Tables
Table 1. Global Nuclear Medicine & Radiopharmaceuticals Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Nuclear Medicine & Radiopharmaceuticals Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Nuclear Medicine & Radiopharmaceuticals Market Competitive Situation by Manufacturers in 2022
Table 4. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Nuclear Medicine & Radiopharmaceuticals Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Nuclear Medicine & Radiopharmaceuticals, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Nuclear Medicine & Radiopharmaceuticals, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Nuclear Medicine & Radiopharmaceuticals, Product Type & Application
Table 12. Global Key Manufacturers of Nuclear Medicine & Radiopharmaceuticals, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nuclear Medicine & Radiopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine & Radiopharmaceuticals as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nuclear Medicine & Radiopharmaceuticals Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Nuclear Medicine & Radiopharmaceuticals Sales by Region (2018-2023) & (K Units)
Table 18. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2018-2023)
Table 19. Global Nuclear Medicine & Radiopharmaceuticals Sales by Region (2024-2029) & (K Units)
Table 20. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2024-2029)
Table 21. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2018-2023)
Table 23. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2024-2029)
Table 25. North America Nuclear Medicine & Radiopharmaceuticals Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2018-2023) & (K Units)
Table 27. North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2024-2029) & (K Units)
Table 28. North America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2018-2023) & (K Units)
Table 32. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2024-2029) & (K Units)
Table 33. Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Nuclear Medicine & Radiopharmaceuticals Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Type (2018-2023)
Table 51. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Type (2024-2029)
Table 52. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2018-2023)
Table 53. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2024-2029)
Table 54. Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2018-2023)
Table 57. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2024-2029)
Table 58. Global Nuclear Medicine & Radiopharmaceuticals Price (USD/Unit) by Type (2018-2023)
Table 59. Global Nuclear Medicine & Radiopharmaceuticals Price (USD/Unit) by Type (2024-2029)
Table 60. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Application (2018-2023)
Table 61. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Application (2024-2029)
Table 62. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2018-2023)
Table 63. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2024-2029)
Table 64. Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2018-2023)
Table 67. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2024-2029)
Table 68. Global Nuclear Medicine & Radiopharmaceuticals Price (USD/Unit) by Application (2018-2023)
Table 69. Global Nuclear Medicine & Radiopharmaceuticals Price (USD/Unit) by Application (2024-2029)
Table 70. China Isotope & Radiation Corporation Information
Table 71. China Isotope & Radiation Description and Business Overview
Table 72. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product
Table 74. China Isotope & Radiation Recent Developments/Updates
Table 75. Dongcheng Corporation Information
Table 76. Dongcheng Description and Business Overview
Table 77. Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Dongcheng Nuclear Medicine & Radiopharmaceuticals Product
Table 79. Dongcheng Recent Developments/Updates
Table 80. Jaco Corporation Information
Table 81. Jaco Description and Business Overview
Table 82. Jaco Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Jaco Nuclear Medicine & Radiopharmaceuticals Product
Table 84. Jaco Recent Developments/Updates
Table 85. Ciaeriar Corporation Information
Table 86. Ciaeriar Description and Business Overview
Table 87. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product
Table 89. Ciaeriar Recent Developments/Updates
Table 90. Advanced Molecular-imaging Solution Corporation Information
Table 91. Advanced Molecular-imaging Solution Description and Business Overview
Table 92. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product
Table 94. Advanced Molecular-imaging Solution Recent Developments/Updates
Table 95. Shanghai Atom Kexing Corporation Information
Table 96. Shanghai Atom Kexing Description and Business Overview
Table 97. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product
Table 99. Shanghai Atom Kexing Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Nuclear Medicine & Radiopharmaceuticals Distributors List
Table 103. Nuclear Medicine & Radiopharmaceuticals Customers List
Table 104. Nuclear Medicine & Radiopharmaceuticals Market Trends
Table 105. Nuclear Medicine & Radiopharmaceuticals Market Drivers
Table 106. Nuclear Medicine & Radiopharmaceuticals Market Challenges
Table 107. Nuclear Medicine & Radiopharmaceuticals Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Nuclear Medicine & Radiopharmaceuticals
Figure 2. Global Nuclear Medicine & Radiopharmaceuticals Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Nuclear Medicine & Radiopharmaceuticals Market Share by Type in 2022 & 2029
Figure 4. Diagnostic Product Picture
Figure 5. Therapeutic Product Picture
Figure 6. Global Nuclear Medicine & Radiopharmaceuticals Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Nuclear Medicine & Radiopharmaceuticals Market Share by Application in 2022 & 2029
Figure 8. Oncology
Figure 9. Thyroid
Figure 10. Cardiology
Figure 11. Others
Figure 12. Global Nuclear Medicine & Radiopharmaceuticals Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Nuclear Medicine & Radiopharmaceuticals Market Size (2018-2029) & (US$ Million)
Figure 14. Global Nuclear Medicine & Radiopharmaceuticals Sales (2018-2029) & (K Units)
Figure 15. Global Nuclear Medicine & Radiopharmaceuticals Average Price (USD/Unit) & (2018-2029)
Figure 16. Nuclear Medicine & Radiopharmaceuticals Report Years Considered
Figure 17. Nuclear Medicine & Radiopharmaceuticals Sales Share by Manufacturers in 2022
Figure 18. Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Nuclear Medicine & Radiopharmaceuticals Players: Market Share by Revenue in 2022
Figure 20. Nuclear Medicine & Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Nuclear Medicine & Radiopharmaceuticals Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2018-2029)
Figure 23. North America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2018-2029)
Figure 24. U.S. Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2018-2029)
Figure 27. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2018-2029)
Figure 28. Germany Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2018-2029)
Figure 35. China Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2018-2029)
Figure 45. Latin America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Nuclear Medicine & Radiopharmaceuticals by Type (2018-2029)
Figure 55. Global Revenue Market Share of Nuclear Medicine & Radiopharmaceuticals by Type (2018-2029)
Figure 56. Global Nuclear Medicine & Radiopharmaceuticals Price (USD/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Nuclear Medicine & Radiopharmaceuticals by Application (2018-2029)
Figure 58. Global Revenue Market Share of Nuclear Medicine & Radiopharmaceuticals by Application (2018-2029)
Figure 59. Global Nuclear Medicine & Radiopharmaceuticals Price (USD/Unit) by Application (2018-2029)
Figure 60. Nuclear Medicine & Radiopharmaceuticals Value Chain
Figure 61. Nuclear Medicine & Radiopharmaceuticals Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed